Key stats
About KODEX SYNTH-US BIO
Expense ratio
0.25%
Home page
Inception date
Oct 31, 2013
ISIN
KR7185680006
KODEX Synth-US bio mainly focuses on USA's biotechnology companies committed to healthier future.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Cash
Miscellaneous
Bonds, Cash & Other100.00%
Cash50.24%
Miscellaneous43.49%
ETF6.27%
Stock breakdown by region
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history